Skip to main content

Table 1 Overview of the patient’s characteristics

From: Volatile versus propofol sedation after cardiac valve surgery: a single-center prospective randomized controlled trial

 

Volatile

Intravenous

All

n =

47 (50%)

47 (50%)

94 (100%)

Sex (male, %)

33 (70.2%)

33 (70.2%)

66 (70.2%)

Age (years)

60 (IQR 51; 69)

64 (IQR 57; 71)

62 (IQR 54; 71)

Diabetes mellitus

9 (19.1%)

6 (12.8%)

15 (16.0%)

Hyperlipidemia

19 (40.4%)

15 (31.9%)

34 (36.2%)

Chronic renal failure

3 (6.4%)

6 (12.8%)

9 (9.6%)

Arterial hypertension

36 (76.6%)

34(72.3%)

70 (74.5%)

Smoking

6 (12.8%)

7 (14.8%)

13 (13.8%)

BMI (kg/m2)

26.3 (IQR 23.4; 29.0)

25.0 (IQR 23.0; 28.7)

25.8 (IQR 23.3; 28.7)

Euro II Score

1.18 (IQR 0.78; 1.84)

1.30 (IQR 0.88; 2.13)

1.24 (IQR 0.81; 2.07)

Mitral valve surgery

25 (53.2%)

25 (53.2%)

50 (53.2%)

Tricuspid valve surgery

3(6.4%)

5(10.6%)

8 (8.5%)

Aortic valve surgery

22 (46.8%)

21 (44.7%)

43 (45.7%)

Combined Surgery

3 (6.4%)

4 (8.5%)

7 (7.4%)

  1. Clinical characteristics of the patients included in the study correspond to the sedation intervention groups and in total. Data are presented as median with interquartile range (IQR) or as patient number (percentage) where applicable
  2. kg, kilogram; m2, square meters